Truncated Streptococcus pneumoniae PspA molecules elicit cross-protective immunity against pneumococcal challenge in mice
- PMID: 8568299
- DOI: 10.1093/infdis/173.2.380
Truncated Streptococcus pneumoniae PspA molecules elicit cross-protective immunity against pneumococcal challenge in mice
Abstract
Immunization with pneumococcal surface protein A (PspA) from Streptococcus pneumoniae strain Rx1 cross-protects mice against challenge with diverse pneumococci. Truncated Rx1 PspA, consisting of amino acids 192-588, elicits protection against the mouse-virulent strain WU2. The possibility that homologous regions of other PspAs could also elicit cross-protection was investigated. Oligonucleotide primers designed according to the Rx1 pspA gene sequence were used to amplify chromosomal DNA from 15 diverse pneumococci. Three recombinant PspAs were evaluated for their ability to elicit protection in mice against challenge with 7 strains representing capsular types 3, 4, 5, 6A, and 6B. Two of the three truncated PspAs each elicited cross-protection against 71%-100% of the S. pneumoniae challenge strains examined. These data suggest that this technique may be useful for the generation of diverse PspAs for inclusion in a broadly protective pneumococcal vaccine.
Similar articles
-
Comparison of the PspA sequence from Streptococcus pneumoniae EF5668 to the previously identified PspA sequence from strain Rx1 and ability of PspA from EF5668 to elicit protection against pneumococci of different capsular types.Infect Immun. 1998 Oct;66(10):4748-54. doi: 10.1128/IAI.66.10.4748-4754.1998. Infect Immun. 1998. PMID: 9746574 Free PMC article.
-
PspA family fusion proteins delivered by attenuated Salmonella enterica serovar Typhimurium extend and enhance protection against Streptococcus pneumoniae.Infect Immun. 2009 Oct;77(10):4518-28. doi: 10.1128/IAI.00486-09. Epub 2009 Aug 17. Infect Immun. 2009. PMID: 19687204 Free PMC article.
-
Localization of protection-eliciting epitopes on PspA of Streptococcus pneumoniae between amino acid residues 192 and 260.Microb Pathog. 1994 Nov;17(5):323-37. doi: 10.1006/mpat.1994.1078. Microb Pathog. 1994. PMID: 7723659
-
Systemic and mucosal protective immunity to pneumococcal surface protein A.Ann N Y Acad Sci. 1996 Oct 25;797:118-26. doi: 10.1111/j.1749-6632.1996.tb52954.x. Ann N Y Acad Sci. 1996. PMID: 8993356 Review.
-
Protective immunity elicited by rBCG vaccines.Dev Biol Stand. 1994;82:163-70. Dev Biol Stand. 1994. PMID: 7958471 Review.
Cited by
-
Panproteome-wide analysis of antibody responses to whole cell pneumococcal vaccination.Elife. 2018 Dec 28;7:e37015. doi: 10.7554/eLife.37015. Elife. 2018. PMID: 30592459 Free PMC article. Clinical Trial.
-
Novel Immunoprotective Proteins of Streptococcus pneumoniae Identified by Opsonophagocytosis Killing Screen.Infect Immun. 2018 Aug 22;86(9):e00423-18. doi: 10.1128/IAI.00423-18. Print 2018 Sep. Infect Immun. 2018. PMID: 29891544 Free PMC article.
-
Towards Identifying Protective B-Cell Epitopes: The PspA Story.Front Microbiol. 2017 May 2;8:742. doi: 10.3389/fmicb.2017.00742. eCollection 2017. Front Microbiol. 2017. PMID: 28512452 Free PMC article. Review.
-
Pneumococal Surface Protein A (PspA) Regulates Programmed Death Ligand 1 Expression on Dendritic Cells in a Toll-Like Receptor 2 and Calcium Dependent Manner.PLoS One. 2015 Jul 27;10(7):e0133601. doi: 10.1371/journal.pone.0133601. eCollection 2015. PLoS One. 2015. PMID: 26214513 Free PMC article.
-
Development of Streptococcus pneumoniae Vaccines Using Live Vectors.Vaccines (Basel). 2014 Jan 7;2(1):49-88. doi: 10.3390/vaccines2010049. Vaccines (Basel). 2014. PMID: 25309747 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical